Cardioxyl Pharma Raises Series A

Cardioxyl Pharmaceuticals Inc., a Towson, Md.-based drug company focused on cardiovascular disease, has raised $14.5 million in Series A funding. The Aurora Funds and New Enterprise Associates co-led the deal. www.cardioxyl.com